article Open AccessTop 1% cited

Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma

British journal of surgery · 2004 · Vol. 91(5) · pp. 586–594

Markus Wagner✉(University of Bern)C. Redaelli(University of Bern)Michael Lietz(University of Bern)C Seiler(University of Bern)Helmut Friess(University of Bern)Markus W. Büchler(University of Bern)

View via DOI Full-text PDF

Abstract

Resection for pancreatic adenocarcinoma can be performed safely. The overall survival rate is determined by the radicality of resection. Patients deemed fit for surgery who have no radiological signs of distant metastasis should undergo surgical exploration. Resection should follow if there is a reasonable likelihood that an R0 resection can be obtained.

Pancreatic and Hepatic Oncology Research Pancreatitis Pathology and Treatment Neuroendocrine Tumor Research AdvancesMedicineSurgeryAdenocarcinomaStage (stratigraphy)PancreatectomyPancreatic cancerSurvival rateProportional hazards modelSurvival analysisResection

MeSH terms

AdenocarcinomaAdultAgedAged, 80 and overFemaleGastric EmptyingHumansMaleMiddle AgedPancreatic NeoplasmsPostoperative ComplicationsProspective StudiesRisk FactorsSurvival RateSurvival Analysis

Citations

845

FWCI

15.63

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Most Pancreatic Cancer Resections are R1 Resections